The roche cobas r 4800 and cobas r 6800 systems and associated reagents are validated, pepfar approved, who prequalified, and FDA approved for HIV viral load and early infant diagnosis EID testing and…
Ended Awarded Last action
- Contract number
- 75D30124F00073
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $130,151
Award facts
- Opportunity
-
- 2024EJH00249 Solicitation number
- Contract value 100% obligated
- $130,151.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $130,151 |
About this award
Roche Diagnostics Corporation received a delivery order valued at $130,151.30 from the Centers for Disease Control and Prevention (CDC) on August 21, 2024, for Roche COBAS R 4800 and COBAS R 6800 molecular diagnostic systems and associated reagents. These validated platforms are approved by PEPFAR (President's Emergency Plan for AIDS Relief), WHO prequalified, and FDA-cleared for HIV viral load and early infant diagnosis (EID) testing. The order is a child contract under the GSA Critical Analyzers, Laboratory schedule (FSS-66-III) and carries a firm fixed-price structure with a completion date of August 1, 2025. The place of performance is Castleton, Indiana, and no set-aside designation was used in the award.
This delivery order supports CDC's infectious disease diagnostic capabilities, aligning with the agency's mission to provide advanced testing solutions for HIV detection and monitoring. Roche Diagnostics Corporation has an extensive federal contracting history across the Department of Veterans Affairs, Defense Health Agency, and other civilian healthcare agencies, with multiple active indefinite delivery contracts and blanket purchase agreements for laboratory analyzers, reagents, and diagnostic services. The COBAS platforms represent critical infrastructure for high-volume molecular testing in clinical and public health laboratory settings, particularly for infectious disease surveillance and patient management.
Description
The roche cobas r 4800 and cobas r 6800 systems and associated reagents are validated, pepfar approved, who prequalified, and FDA approved for HIV viral load and early infant diagnosis EID testing and meets the requirements needed to perform HIV vira
Quick answers
Who was awarded contract 75D30124F00073?
75D30124F00073 was awarded to Roche Diagnostics Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 21, 2024.
How much is contract 75D30124F00073 worth?
The government has obligated $130,151 on 75D30124F00073.
Is contract 75D30124F00073 an order under another contract?
Yes. 75D30124F00073 is a delivery order under V797D70105, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 75D30124F00073 competed?
The extent of competition for 75D30124F00073 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award